HH-Medic
和缓医疗
HH-Medic (和缓医疗) is an internet healthcare company focused on solving problems of accessibility in medical services, backed by FreeS Fund — the fund has cited it, alongside Nuoxin Chuanglian, as part of its internet-medical portfolio addressing 医疗服务的可及性 . Beyond that, elsewhere's corpus is thin: the references here are FreeS Fund pieces from 2020–2021 framing it within their healthcare-investment thesis, so there's no material on its founding details, products, or recent developments.
AI-generated — may contain errors, please verify.
Coverage
New Opportunities Amid the Great Transformation in Drug R&D | FreeS Fund Dialogue Session 2 Now Open for Registration
Breakthroughs and Acceleration in New Drug R&D
Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
FreeS Fund Healthcare Open Day Is Here: Entering the Grand Era of Biomedical Innovation
Looking for China's Genentech, Moderna, Alnylam, Spark, Nimbus Therapeutics
The New Era of "Good Companies" After the Pandemic | Frees Fund
Industry Outlook for 2020 Amid the Pandemic
春天里的9份收获和4点洞察 | 峰瑞黑板报·3月
朝前看，坚持做。
A Founder's 365 Days: The Days That Got Us Through, and 22 Amazing Moments | FreeS Fund Year-End Special
Here's to exploration, struggle, and perseverance. Happy New Year!
